Results of a double perfusion schedule with melphalan in patients with melanoma of the lower limb
- 1 January 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (3) , 325-328
- https://doi.org/10.1016/0959-8049(93)90377-r
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limbBritish Journal of Surgery, 1990
- Seven years experience with hyperthermic perfusions in extracorporeal circulation for melanoma of the extremitiesJournal of Surgical Oncology, 1989
- Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. Cytomorphologic changes, initial tumor ploidy, and tumor regressionCancer, 1989
- Value of therapeutic hyperthermic limb perfusion in advanced recurrent melanoma of the lower extremityThe American Journal of Surgery, 1985
- Objective Regression of Unexcised Melanoma in-Transit Metastases After Hyperthermic Isolation Perfusion of the Limbs with MelphalanPublished by Springer Nature ,1983
- Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactionsEuropean Journal of Cancer and Clinical Oncology, 1982
- Tourniquet Infusion Versus Hyperthermic PerfusionCancer, 1982
- Survival and regional disease control after isolation-perfusion for invasive stage I melanoma of the extremitiesCancer, 1976
- Treatment of malignant melanoma by regional perfusionCancer, 1965
- Chemotherapy of CancerAnnals of Surgery, 1958